Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,332.00
Bid: 12,332.00
Ask: 12,336.00
Change: -8.00 (-0.06%)
Spread: 4.00 (0.032%)
Open: 12,414.00
High: 12,414.00
Low: 12,318.00
Prev. Close: 12,340.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-German minister sees COVID-19 vaccine shortage well into April

Thu, 28th Jan 2021 08:55

* Health minister: vaccine shortages to last at least 10
weeks

* Interior ministry preparing entry ban for risk countries

* 7-day incidence falls below 100 cases/100,000 people
(Adds timing of summit)

BERLIN, Jan 28 (Reuters) - Germany faces a shortage of
coronavirus shots well into April, its health minister said on
Thursday, and called for a summit with the country's state
leaders to discuss vaccinations as the government faced fresh
criticism over the pace of the roll-out.

Several people close to the talks told Reuters that the
meeting will take place on Monday.

"We will still have at least 10 tough weeks with a shortage
of vaccine," Jens Spahn said in a Tweet, adding the meeting
should focus on how Europe gets its fair share of shots and what
can be done to support the process.

Germany, like the rest of the European Union, is scrambling
to obtain shots as the West's biggest drugmakers slow deliveries
to the bloc due to production problems.

Germany's top-selling Bild newspaper described the problem
of procuring enough vaccines as a "scandal".

Meanwhile, popular approval of the government's handling of
the coronavirus crisis has dropped to 49%, its lowest since the
start of the pandemic, a poll for the Frankfurter Allgemeine
Zeitung showed.

Spahn said he wanted to invite pharmaceutical companies and
vaccine manufacturers to a meeting to discuss the way forward,
adding he recognised vaccine production was complex and
production could not be built up in a few weeks.

On Tuesday, Spahn supported European Union proposals to set
up a register of vaccine exports, as tensions grow with
AstraZeneca and Pfizer over sudden supply cuts
just a month after the EU started vaccinating citizens.

Germany reported 17,553 new coronavirus cases on Thursday,
bringing the total to 2,178,828, and another 941 deaths. The
seven-day incidence rate fell under 100 cases per 100,000 for
the first time since the end of October. The government wants it
to drop below 50.

Spahn has said that if cases continue to fall, schools and
nurseries should be the first to reopen after a lockdown
currently due to last until Feb. 14.

Germany is also preparing entry restrictions for travellers
from Britain, Brazil and South Africa, the interior ministry
said, and hopes to decide by Friday as concerns mount about more
contagious variants.

"We have to get ahead of the situation," Interior Minister
Horst Seehofer said on Twitter.

(Reporting by Emma Thomasson, Caroline Copley and Andreas
Rinke; Editing by Thomas Seythal, Alex Richardson and Giles
Elgood)

More News
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.